Case 1:15—cv—00087-UNA Document 4 Filed 01/26/15 Page 1 of 1 PageID #: 74
`A0 120 Rev. 08/10
`
`T0:
`
`Mail Stop 8
`Director of the US. Patent and Trademark Office
`P.0. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`
`filed in the US. District Court
`for the District of Delaware
`on the following
`
`I] Trademarks or
`
`[Z Patents.
`
`( E] the patent action involves 35 U.S.C. § 292.):
`
`DOCKET NO.
`
`PLAINTIFF
`
`
`
`
`DATE FILED
`1/26/2015
`
`U.S. DISTRICT COURT
`for the District of Delaware
`
`DEFENDANT
`
`
`
`
`
`SENJU PHARMACEUTICAL CO., LTD., et al.
`
`
`
`PADDOCK LABORATORIES, LLC, et al.
`
`
`
`mm;
`
`
`
`
`
`
`
`
`
`
`
`
`
`4 8 871 813 82
`
`10/28/2014
`
`Senju Pharmaceutical Co., Ltd.
`
`5 8,917 606 B1
`
`1/6/2015
`
`Senju Pharmaceutical Co., Ltd.
`
`DATE INCLUDED
`
`In the above—entitled case, the following patent(s)/ trademark(s) have been included:
`INCLUDED BY
`
`PATENT OR
`TRADEMARK NO.
`
`D Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`1:] Answer
`
`[:1 Cross Bill
`
`[:1 Other Pleading
`
`HOLDER OF PATENT OR TRADEMARK
`
`
`
`
`
`
`
`
`
`
`—_
`-—
`__
`——
`
`
`
`
`In the above—entitled case, the following decision has been rendered 0r judgement issued:
`DECISION/JUDGEMENT
`
`
`
` (BY) DEPUTY CLERK
`
`DATE,
`
`Copy l—Upon initiation of action, mail this copy to Director Copy 3——Upon termination of action, mail this copy to Director
`Copy 2—Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`
`Page 1 of 145
`
`LUPIN EX 1046
`
`LUPIN EX 1046
`
`Page 1 of 145
`
`

`

`Case 1:14—cv-06893—JBS—KMW Document 4 Filed 11/03/14 Page 1 of 1 PagelD: 64
`
`
`
`
`Mail Stop 8
`REPORT ON THE
`
`Director of the U.S(.)lf’tz_:::nt and Trademark
`FILING OR DETERMINATION OF AN
`
`
`ACTION REGARDING A PATENT OR
`p0. Box 1450
`
`
`Alexandria, VA 22313—1450
`TRADEMARK
`
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`filed in the US. District Court for the District of New Jersey on the following:
`Trademarks or X Patents. (
`the patent action involves 35 U.S.C. § 292.)
`
`
`
`U.S. DISTRICT COURT
`DATE FILED
`DOCKET NO.
`CAMDEN NJ
`1:14—cv—06893-JBS—KMW 11/3/2014
`
`DEFENDANT
`
`
`PLAINTIFF
`INNOPHARMA LICENSING, INC.
`
`SENJU PHARMACEUTICAL CO., LTD.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`PATENT OR
`TRADEMARK NO.
`1 3 129 431
`2 3 669 290
`3 8 754131
`
`DATE OF PATENT
`OR TRADEMARK
`
`3/6/2012 “
`
`
`3/11/2014 “
`
`
`6/17/2014
`
`
`4 8 871 813
`10/28/2014
`
`__
`
`
`
`
`
`DECISION/1UDGEMENT
`
`
`
`
` CLERK
`
`(BY) DEPUTY CLERK
`3/ Nicholas Zotti
`
`DATE
`11/3/2014
`
`
`
`William T. Walsh
`
`Copy l—Upon initiation of action, mail this copy to Director Copy 3——Upon termination of action, mail this copy to Director
`Copy 2—Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`
`Page 2 of 145
`
`Page 2 of 145
`
`

`

`A0120 Rev. 08/10
`
`TRADEMARK
`
`TO:
`
`Mail Stop 8
`Director of the US. Patent and Trademark Office
`PO. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`
`filed in the US. District Court
`Eastern District of North Carolina
`on the following
`
`I] Trademarks or
`
`MPatents.
`
`( E! the patent action involves 35 U.S.C. § 292.):
`
`DATE FILED
`8/8/2014
`
`DOCKET NO.
`U.S. DISTRICT COURT
`
`
`4:14-CV-141-BO
`Eastern District of North Carolina
`PLAINTIFF
`DEFENDANT
`
`
`Senju Pharmaceutical Co., Ltd., et ai
`Metrics, Inc., et aI
`
`
`
`
`
`W
`
`__—
`s _—
`
`
`
`DATE INCLUDED
`
`INCLUDED BY
`
`In the above——entitled case, the following patent(s)/ trademark(s) have been included:
`
`
`
`[I Answer
`
`
`
`
`
`
`
`
`
` __—
`
`
`(BY) DEPUTY CLERK
`
`El Cross Bill
`
`[:I Other Pleading
`
`L—_I Amendment
`PATENT OR
`DATE OF PATENT
`TRADEMARK N0.
`OR TRADEMARK
`HOLDER OF PATENT OR TRADEMARK
`__—
`__—
`__—
`__—
`
`In the above—entitled case, the following decision has been rendered or judgement issued:
`DECISION/JUDGEMENT
`
`Copy l—Upon initiation of action, mail this copy to Director Copy 3—Upon termination of action, mail this copy to Director
`Copy Z—Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`Page 3 of 145
`
`Page 3 of 145
`
`

`

`Case 1:14-cv-05144—JBS-KMW Document 3 Filed 08/15/14 Page 1 of 1 PagelD: 23
`
`O 120 Rev. 08/10
`
`
`
`
`
`
`
`
`
`
`Mail Stop 8
`
`
`REPORT ON THE
`.
`FILING OR DETERMINATION OF AN
`Director of the U.Sblggzint and Trademark
`
`
`P O Box 1450
`ACTION REGARDING A PATENT OR
`
`
`'
`'
`TRADEMARK
`
`
`Alexandria, VA 22313—1450
`
`
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`
`filed in the US. District Court for the District of New Jersey on the following:
`Trademarks or X Patents. (
`the patent action involves 35 U.S.C. § 292.)
`
`
`
`
`DATE FILED
`DOCKET NO.
`lil4'CV“05144-JEI*KMW 8/15/2014
`
`
`PLAINTIFF
`
`SENJU PHARMACEUTICAL CO., LTD.
`
`
`
`DATE OF PATENT
`PATENT OR
`HOLDER OF PATENT OR TRADEMARK
`OR TRADEMARK
`TRADEMARK NO.
`
`6/11/2014 m_
`18 754131
`
`
`——_
`
`
`
`
`
`US. DISTRICT COURT
`CAMDEN NJ
`DEFENDANT
`LUPIN, LTD.
`
`
`
`
`
`
`
`Amendment 7_ Answer __ Other Pleading __ Cross Bill
`
`
`
`
`
`DECISION/JUDGEMENT
`
`
`
`
`
`
`
`CLERK
`William T. Walsh
`
`
`
`(BY) DEPUTY CLERK
`s/ Nicholas Zotti
`
`DATE
`8/15/2014
`
`Copy 1——Upon initiation of action, mail this copy to Director Copy 3—-—Upon termination of action, mail this copy to Director
`Copy 2——Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`
`Page 4 of 145
`
`Page 4 of 145
`
`

`

`Case 1:14-cv-O4964—JBS Document 4 Filed 08/07/14 Page 1 of 1 PagelD: 52
`
`0120 Rev. 08/10
`
`Mail Stop 8
`.
`Director of the U.S. Patent and Trademark
`Office
`13.0. Box 1450
`Alexandria, VA 22313—1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`filed in the U.S. District Court for the District of New Jersey on the following:
`Trademarks or X Patents. (
`the patent action involves 35 U.S.C. § 292.)
`
`DOCKET NO.
`1:14-cv—049647JBS
`
`DATE FILED
`8/7/2014
`
`PLAINTIFF
`SENJU PHARMACEUTICAL CO., LTD.
`
`U.S. DISTRICT COURT
`CAMDEN NJ
`
`DEFENDANT
`METRICS, INC.
`
`-__
`—__
`
`
`
`In the above—-entitled case the followin~ atent s / trademark s have been included:
`INCLUDED BY
`DATE INCLUDED
`
`
`
` Amendment
`Answer _ Cross Bill _ Other Pleading
`
`PATENT OR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`
`
`
`
`
`
`
`
`
`In the above-—entitled case the followin_ decision has been rendered or 'ud_ement issued:
`DECISION/JUDGEMENT
`
`CLERK
`William T. Walsh
`
`(BY) DEPUTY CLERK
`3/ Brian D. Kemner
`
`DATE
`8/7/2014
`
`Copy 1—-—Upon initiation of action, mail this copy to Director Copy 3-—Upon termination of action, mail this copy to Director
`Copy 2—Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`
`Page 5 of 145
`
`Page 5 of 145
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMIVHSSIONER FOR PATENTS
`PO. Box 1450
`Alexandria1 Virginia 22313-1450
`www.uspto.gov
`
`APPLICATION NO.
`
`14/165,976
`
`ISSUE DATE
`
`06/17/2014
`
`PATENT NO.
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`8754131
`
`2014—0075
`
`4523
`
`513
`
`7590
`
`05/28/2014
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`Suite 400 East
`
`Washington, DC 20005-1503
`
`The projected patent number and issue date are specified above.
`
`ISSUE NOTIFICATION
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment is 0 day(s). Any patent to issue from the above—identified application will include
`an indication of the adjustment on the front page.
`
`If a Continued Prosecution Application (CPA) was filed in the above—identified application, the filing date that
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information
`Retrieval (PAIR) WEB site (http://pair.uspto. gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the
`Office of Patent Legal Administration at (571)—272—7702. Questions relating to issue and publication fee
`payments should be directed to the Application Assistance Unit (AAU) of the Office of Data Management
`(ODM) at (571)-272-4200.
`
`APPLICANT(S) (Please see PAIR WEB site http://pair.uspto. gov for additional applicants):
`
`SENJU PHARMACEUTICAL CO., LTD., Osaka, JAPAN, Assignee (with 37 CFR 1.172 Interest);
`Shirou SAWA, Hyogo, JAPAN;
`Shuhei FUJITA, Hyogo, JAPAN;
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location
`for business investment, innovation, and commercialization of new technologies. The USA offers tremendous
`resources and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation
`works to encourage and facilitate business investment. To learn more about why the USA is the best country in
`the world to develop technology, manufacture products, and grow your business, visit SelectUSA.gov.
`
`IR103 (1239119309) Of 145
`
`Page 6 of 145
`
`

`

`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`AddIESS. COMMISSIONER FOR PATENTS
`PO Box 1450
`Alexandria, Viigmia 22313-1450
`www.uspto.gov
`
`
`
`
`F ING OR 371 (C) DATE
`
`
`
`APPLICATION NUMBER
`
`FIRST NAMED APPLICANT
`
`ATTY. DOCKET NO./TITLE
`
`14/165,976
`
`01/28/2014
`
`Shirou SAWA
`
`2014-0075
`CONFIRMATION NO. 4523
`
`513
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1oso15ulsneetlvvv,
`Suite 400 East
`
`Washington, DC 20005-1503
`
`PUBLICATION NOTICE
`
`IMINWWWNIme
`
`
`685959 6
`
`WWWWWWWWWMWWILOOOOO
`
`Title:AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC
`ACID
`
`Publication No.US-2014-0142183-A1
`Publication Date:05/22/2014
`
`NOTICE OF PUBLICATION OF APPLICATION
`
`The above-identified application will be electronically published as a patent application publication pursuant to 37
`CFR 1.211, et seq. The patent application publication number and publication date are set forth above.
`
`The publication may be accessed through the USPTO's publically available Searchable Databases via the
`Internet at www.uspto.gov. The direct link to access the publication is currently http://www.uspto.gov/patft/.
`
`The publication process established by the Office does not provide for mailing a copy of the publication to
`applicant. A copy of the publication may be obtained from the Office upon payment of the appropriate fee set forth
`in 37 CFR 1.19(a)(1). Orders for copies of patent application publications are handled by the USPTO's Office of
`Public Records. The Office of Public Records can be reached by telephone at (703) 308-9726 or (800) 972-6382,
`by facsimile at (703) 305-8759, by mail addressed to the United States Patent and Trademark Office, Office of
`Public Records, Alexandria, VA 22313-1450 or via the Internet.
`
`In addition, information on the status of the application, including the mailing date of Office actions and the
`dates of receipt of correspondence filed in the Office, may also be accessed via the Internet through the Patent
`Electronic Business Center at www.uspto.gov using the public side of the Patent Application Information and
`Retrieval (PAIR) system. The direct link to access this status information is currently http://pair.uspto.gov/. Prior to
`publication, such status information is confidential and may only be obtained by applicant using the private side of
`PAIR.
`
`Further assistance in electronically accessing the publication, or about PAIR, is available by calling the Patent
`Electronic Business Center at 1-866-217-9197.
`
`
`
`Office of Data Managment, Application Assistance Unit (571) 272-4000, or (571) 272-4200, or 1-888-786-0101
`
`page 1 of 1
`
`Page 7 of 145
`
`Page 7 of 145
`
`

`

`(711111111010 211111515111 11115; 1111111, 11515501111111 11-1111 11151511131111:1'1:e{s}.t171 1111,1111,
`
`PA RT 13 ~ FEMS) TEA NSMI".1"’1'AL
`
`13111111811111 1851.1'1'1' 1Eit
`1unlnlissimwr 1151‘ Patents
`P1} 3111: 14511
`«91117111111111‘111, V“ginia "12511344511
`
`01: £1111; (5713—273-2S85
`
`
`
`
`
`
`
`
`‘1 11111711211:
`13111111.;
`1531311
`25111711111
`111: 17171111713111! when:
`(11:11:;1111111).
`‘3: 1111.1 1171111 1111111111171:
`1
`.1
`'Z~
`1111‘. 1S
`.1? 1'1'i1::‘.11n11 91131.1(.1‘11'101‘11“ 1131::
`11.11 11.111131111111311;
`
`
`1111 1.71;! 111111111 11.1 1111‘. cum::1! 1171‘1'
`75311135312: 1111111‘w‘k
`1
`1111;511:1711.
`..
`-11 1'111‘11‘11‘
`~<
`117171.\p1‘1‘1111‘111 1111111111113: 1111. 1111113511351
`71‘1 1.13 211111 1317111'111
`711 11f 11.131111111111117;
`
`:1 195‘11111111;
`31131)}?
`1111113111111 15111-313 mm‘1.11‘11 111:1:111'171 111111215311 171111111111». 111 1711011117}- 111} 1111:011yi11g :1. 1111.11-111111x17171117‘111‘1‘. addufi: 111111.111; {17} 11111112111111;
`31131111811111‘11‘81'131‘. 11171151131101'15.
`
`
`1111‘
`‘1 11:1111‘1'1‘1111': 17? 1112111111,: 1:11.11me 1.7:;- 11s~11 11.71 1117111121111 111;:
`1‘1 1.11
`N '
`
`
`
`113131111172 151.155.1911 11'.)
`'
`1.1
`11311111111" H155. 11311513
`“pun-1555;
`
`
`
`171111.111 111‘m'vi11g. 1111111
`such 11$ 1‘11}
`Fapt‘.‘
`{3111:}! 1513111111
`211 11:11.7.
`1.11-1‘ 115 mm lit‘l‘iifil.1111‘ 171' 5113511113. 151' Ll.11‘1\1111\\5011
`
`(.‘1FRI-16$"? 1' .{1 Ex
`
`II."
`
`$17 {Na-11‘: 131:: 81.17151 1' 11:1 my 11:11:37; 171’ 1:111:11;
`
`
`
`1'31.11117111. 1.117117 .11 P011 15711.. 1.1.13.
`
`
`:1 {130 1.7111 111111111. N.W..
`Suite. 400 1321111
`Washing (.151, D117. 21.10115- 1503
`
`.71‘1‘111‘c.1117 1'11 \iiniling 131‘ Tramirtission
`-
`111-11 «1111 1111:. 1511111711
`
`
`
`.
`.13 1111111 1'33 311 8115.1: 111311:
`
`..
`{11515113.
`1'11 being 011131111111:
`.. 1.511 1111‘. 11111‘ 1111111: 1111:11 171111711.
`
`
`
`
`
`
`
`
`('EC'JNEERM.-“1ii'§{)z\" NC). 1N11131117511103" NU. FILING: 131N173 FIRSTNAMED.1N’N’1'LN'E'"'ZIE% 11’1")"1'2RNEEN" IKIK'TKEE' NO. '
`14.1" 1 1113.971.
`1'1 1138521“)1 «=1
`311111.111 HANNA
`'21" i 4101'"?-
`4533.
`
`:3 1 ‘ :"1'1C ACID
`1111.17 01'" 1NN‘EN1'1UN: AQT'
`
`
`
`
`
`
`
`
`$1391N E‘YPE
`
`
`
`13'" .":"131.114'13
`1101153171111 1111111111
`1.351131115153131 ‘ N'l'iii'}
`
`
`'
`‘
`‘
`11
`,
`1"
`-
`1'1
`“
`1‘.
`*'
`'
`1?. .:"'.‘ .
`1‘1"" 7'3"
`:1'
`
`
`.1111;
`\
`1
`7
`1171 51511111511 1111111 pm111
`r7111:5.'1<;.15.<|
`iWENL‘EROTH, LINDS: PUNACRJJ 9_
`H} "1111‘. 111111128 1‘11 up 11.1 '1 1'tss'ik15a'csd 17‘1“‘11: 111115511111
`...................................................................
`1
`
`11151711331136. 171C1'71‘1'11511'111111111‘1-
`111 213‘ms {111. 11111111111111»
`
`.
`.
`
`1111' ”Ami; 1’11 3. wiggle {11m 33,31.an35-: 11 gm;htixj‘ 1}
`15111111 5111‘. mums of up11':
`
`
`"'911'1'1'1'51
`'111 S 111' (1:3“1112. 11' 111': 11151318 1S
`
`
`
`1 1'.11351515: 111'1‘J111r1‘5115551115511: 511111113528 171‘ 53151113551017 17.1" "§"'r:1':
`1'.11'1. 1 5171')
`
`111‘‘111‘1‘ 2111115171
`'3 {7111111151 111" c1111
`Addfi‘SF; 1155111 1'“
`12.211111111111711.
`
`
`Mick-e.
`'
`.111 "
`.,
`'1111'1'11'111113131‘1'1
`
`
`’{13’1321’1'1‘11-3fl“ 5
`55:31 311115515351.
`BRIEF
`
`
`
`
`5 1 11-13133000
`
`31
`-—...................................................................
`j",
`
`
`"15-115 11.531) 111(1311711131’1171i171.111" '
`‘1‘1'1’3‘ 111i- ?RIN'HS'D €be 131.11 13131111151" 11.111111 1111171712)
`
`
`
`5.:5:11:35 1111 .
`$311171
`
`11' (151 3.131%.“1‘. 1'1. 11117111111111 179115111. 1111‘. 51172151119111 11:15. 1.11351 flied far
`«11 17171111111117 amigm‘t‘ 11.1111 11.1.11 agugwém' on 1111‘. 1.1310511
`15-1111
`
`.7171
`5. 1311011171 11111 117111113 .N""01 :1 3111711111111711'11 111111;: 1111'.
`41111113115.
`
`
`
`.11: (1".11'1’ and 5.1
`'53.
`1'5. 011 1'_'.1'.)'€.'-N'1‘RY)
`
`~11) .
`
`{15132153 . Japan
`
`1711111711111}; 3 {1171;171‘11155gr11
`-_l 1.155171711111751 171 1711512.: 17111.11
`' 11'}'
`:1 1111111-1'1115;1i
`
`
`
`411 "1111‘. 11:11.1171711‘19 1113171111 51117111111135}:
`41.7. “131110.111 1511311915): {P1151917 171511 11-11991}- miy p‘rt‘vi111‘1513 paid 1551.1» 121‘. Shawn show)
`
`
`
`3} 1.111111. 511.11.
`:1 A 11111115115: enclosed
`11..) {31511111715117}; 151:9 (N17 5.1111111 11111113 (1111;111:111 1.711111711112115
`J Fax-1111111 1:131: 111‘.1111mm 1“71m‘1‘1‘6‘31“}.‘1‘1‘13‘‘111‘13‘11’11‘11‘
`
`
`‘111'1‘.“(:1',‘~. 11111 (11-11111-111'111‘1z1'q111'5. 1515'
`:1 1111: D111“11.111 is; 11910151 51111111151511‘11 115 1,
`'1; 173.1511
`13 3‘11! ‘1-‘51’111'11‘. 1.1111171 _ 3'1 151111717111
`
`
`
`-
`1175111).
`1111191111111‘111 11'7'111‘171'7811 ."11'11‘1711111 N mix‘
`‘
`:7 Change in {7.1115131 811115.11 11mm 71:15:11; 5511111‘1551‘‘11 15111.7“1‘3
`:3 .3117171112‘1111wrtifyingmim‘n 1111111; 11.11115. See .‘11 1112.1
`
`
`
`V1:
`
`
`
`‘ 131311351 and 15111.113111‘
`' =Nh11‘511 11 1111111 csmifi'caiiun 131' 111111511 131111131
`,
`,
`
`
`
`{519551.111 1111‘. micro 65.11115“ 315511115111 wii! 51111 17“ 11.1
`.1 [.1515 1:115 1711 1117:1111111711111‘5511.
`fer: p
`pit-'1'} :11 the 1'1\
`111
`\___(_________H'1"': 11 1351!.'11311111151111“ was 575315111115.h- 111111131 1111131111 14511ij 31.111113. 11513-1. 1.5551] 11115 box “1111.76 1.151155
`1.71711‘ 111117111111111'17111111111111 171' 15111111111211 11:1 11111711) 111111 55.11115
`
`U 91115511131551 331116511555; 21111111 11531111» 51111113. St‘t‘ 11'1" 1.717171 1.33
`,...
`
`
`
`11 155D19Ita||y signed byWt11311111111 11115- 17173 111111 171‘ "18.11181! 117179 11111111111711111711 1'51" 11751, 1'51"‘11111¥1:1111':111 117 51113.11 01‘ 117111111
`
`‘11111115.1.1111511.155.11.11"‘ 1...!13111111117111“changing 7
`
`Cheek, Jr./
`17551113 111115.111117171114'111
`
`ee
`r
`“=15
`I
`°
`Date: 201 4.05 .07 13:54:59 —04'00'
`
`3.111111111111711 3111113111117
`
`1.111119 '1"}7171‘.11 111‘ 5151111131 51.15551:
`
`Page 8 of 145
`
`11111311521713
`
`1’10}.85 P1111131: '10 11} :‘11'5171‘11771711 111111111: iimmgh 1131711130.}.7
`
`(31131130551003
`
`
`U..\.' 1711112111 {11111 1'11111311111111501‘1'11'13:1.355.131"F.<‘11H'17§ N1 01-" (EDNA-N "
`
`Page 8 of 145
`
`

`

`Electronic Patent Application Fee Transmittal
`
`Filing Date:
`
`28-Jan-2014
`
`T'tle °f Inventwn‘
`
`AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-
`BROMOBENZOYL)PHENYLACETIC ACID
`
`Utility under 35 USC111(a) Filing Fees
`
`Description
`
`Fee Code
`
`Quantity
`
`Sub-Total in
`
`USD($)
`
`_—
`
`
`
`Basic Filing:
`
`Miscellaneous Filing:
`
`Patent Appeals and-Interference:
`
`Post-Al|owance-and-Post-lssuance:
`
`Extensawéfii'l‘fé
`
`Page 9 of 145
`
`

`

`Miscellaneous:
`
`Total in USD (5)
`
`Page 10 of 145
`
`Page 10 of 145
`
`

`

`Electronic Acknowledgement Receipt
`
`“—
`
`——
`
`T'tle °f Inventwn‘
`
`AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-
`BROMOBENZOYL)PHENYLACETIC ACID
`
`
`
`——
`
`Payment information:
`
`yes—
`Submitted with Payment
`
`CHEEKJR., WARREN M.
`
`figgrgq artyffiiqgitional Fees required under 37 C.F.R. Section 1.17 (Patent application and reexamination processing fees)
`
`—Authorized User
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.16 (National application filing, search, and examination fees)
`
`Page 11 of 145
`
`

`

`Charge any Additional Fees required under 37 C.F.R. Section 1.19 (Document supply fees)
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.20 (Post Issuance fees)
`
`Charge any Additional Fees required under 37 C. F. R. Section 1. 21 (Miscellaneous fees and charges)
`
`File Listing:
`
`Document
`
`.
`
`.
`
`File Size(Bytes)/
`
`Multi
`
`Pages
`
`Issue Fee Payment (PTO-85B)
`
`AttachA_IF.pdf
`
`418761
`
`367b87c3f74ec7e02944d8e849d91c93e3e
`6cc09
`
`The PDF file has been signed with a digital signature and the legal effect of the document will be based on the contents of the file not the
`digital signature.
`
`Fee Worksheet (SB06)
`
`fee-info.pdf
`
`b9767fed8cc5cf295f86eae8ec66cb5fe5e9b
`106
`
`
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO ofthe indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 111
`lfa new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)—(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International Application under 35 U.S.C. 371
`lfa timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International Application Filed with the USPTO as a Receiving Office
`lfa new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and ofthe International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`Page 12 of 145
`
`Page 12 of 145
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`PO. Box 1450
`Alexandria1 Virginia 22313-1450
`www.uspto.gov
`
`NOTICE OF ALLOWANCE AND FEE(S) DUE
`
`513
`
`7590
`
`04/21/2014
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`511.641.1113..
`
`Washington, DC 20005-1503
`
`
`
`
`
`SOROUSH,LAYLA
`
`1627
`
`DATE MAILED: 04/21/2014
`
`14/165,976
`
`01/28/2014
`
`Shirou SAWA
`
`2014—0075
`
`4523
`
`TITLE OF INVENTION: AQUEOUS LIQUID PREPARATION CONTAINING 2—AMINO—3—(4—BROMOBENZOYL)PHENYLACETIC ACID
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE
`
`PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATE DUE
`
`nonprovisional
`
`UNDISCOUNTED
`
`$960
`
`$0
`
`$0
`
`$960
`
`07/21/2014
`
`THE APPLICATION IDENTIFIED ABOVE HAS BEEN EXAMINED AND IS ALLOWED FOR ISSUANCE AS A PATENT.
`PROSECUTION ON THE MERITS IS CLOSED. THIS NOTICE OF ALLOWANCE IS NOT A GRANT OF PATENT RIGHTS.
`THIS APPLICATION IS SUBJECT TO WITHDRAWAL FROM ISSUE AT THE INITIATIVE OF THE OFFICE OR UPON
`PETITION BY THE APPLICANT. SEE 37 CFR 1.313 AND MPEP 1308.
`
`THE ISSUE FEE AND PUBLICATION FEE (IF REQUIRED) MUST BE PAID WITHIN THREE MONTHS FROM THE
`MAILING DATE OF THIS NOTICE OR THIS APPLICATION SHALL BE REGARDED AS ABANDONED.
`THIS
`STATUTORY PERIOD CANNOT BE EXTENDED.
`SEE 35 U.S.C. 151. THE ISSUE FEE DUE INDICATED ABOVE DOES
`NOT REFLECT A CREDIT FOR ANY PREVIOUSLY PAID ISSUE FEE IN THIS APPLICATION.
`IF AN ISSUE FEE HAS
`PREVIOUSLY BEEN PAID IN THIS APPLICATION (AS SHOWN ABOVE), THE RETURN OF PART B OF THIS FORM
`WILL BE CONSIDERED A REQUEST TO REAPPLY THE PREVIOUSLY PAID ISSUE FEE TOWARD THE ISSUE FEE NOW
`DUE.
`
`HOW TO REPLY TO THIS NOTICE:
`
`I. Review the ENTITY STATUS shown above. If the ENTITY STATUS is shown as SMALL or MICRO, verify whether entitlement to that
`entity status still applies.
`
`If the ENTITY STATUS is the same as shown above, pay the TOTAL FEE(S) DUE shown above.
`
`If the ENTITY STATUS is changed from that shown above, on PART B - FEE(S) TRANSMITTAL, complete section number 5 titled
`"Change in Entity Status (from status indicated above)".
`
`For purposes of this notice, small entity fees are 1/2 the amount of undiscounted fees, and micro entity fees are 1/2 the amount of small entity
`fees.
`
`II. PART B - FEE(S) TRANSMITTAL, or its equivalent, must be completed and returned to the United States Patent and Trademark Office
`(USPTO) with your ISSUE FEE and PUBLICATION FEE (if required). If you are charging the fee(s) to your deposit account, section "4b"
`of Part B - Fee(s) Transmittal should be completed and an extra copy of the form should be submitted. If an equivalent of Part B is filed, a
`request to reapply a previously paid issue fee must be clearly made, and delays in processing may occur due to the difficulty in recognizing
`the paper as an equivalent of Part B.
`
`III. All communications regarding this application must give the application number. Please direct all communications prior to issuance to
`Mail Stop ISSUE FEE unless advised to the contrary.
`
`IMPORTANT REMINDER: Utility patents issuing on applications filed on or after Dec. 12, 1980 may require payment of
`maintenance fees. It is patentee's responsibility to ensure timely payment of maintenance fees when due.
`
`Page 13 of 145
`PTOL—85 (Rev. 02/11)
`
`Page 1 0f 3
`
`Page 13 of 145
`
`

`

`PART B - FEE(S) TRANSMITTAL
`
`Complete and send this form, together with applicable fee(s), to: Mail Mail Stop ISSUE FEE
`Commissioner for Patents
`PO. Box 1450
`Alexandria, Virginia 22313-1450
`or m (571)-273-2885
`
`through 5 should be completed where
`INSTRUCTIONS: This form should be used for transmitting the ISSUE FEE and PUBLICATION FEE (if required). Blocks 1
`ap ropriate. All further correspondence including the Patent, advance orders and notification of maintenance fees will be mailed to the current correspondence address as
`indicated unless corrected below or directed otherwise in Block 1, by (a) specifying a new correspondence address; and/or (b) indicating a separate "FEE ADDRESS" for
`maintenance fee notifications.
`
`CURRENT CORRESPONDENCE ADDRESS (Note: Use Block 1 for any change ofaddFESS)
`
`04/21/2014
`7590
`513
`WENDEROTH, LIND & PONACK, L...LP
`1030 15th St
`t N W
`.
`1‘66 ’
`'
`Su1te 400 East
`
`"
`
`Washlngton, DC 20005-1503
`
`Note: A certificate of mailin can only be used for domestic mailings of the
`Fee(s) Transmittal. This certi icate cannot be used for any other accompanying
`apers. Each additional paper, such as an assignment or formal drawing, must
`gave its own certificate of mailing or transmission.
`Certificate of Mailing or Transmission
`I hereby certify that this Fee(s) Transmittal is being deposited with the United
`States Postal Service with sufficient postage for first class mail in an envelope
`addressed to the Mail Stop ISSUE FEE address above, or being facsimile
`transmitted to the USPTO (571) 273—2885, on the date indicated below.
`
`(Date)
`
`(Depositorsname)
`(Signature)
`
`APPLICATION NO.
`
`FILING DATE
`
`
`
`
`
` F {ST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`14/165,976
`
`01/28/2014
`
`Shirou SAWA
`
`2014—0075
`
`4523
`
`TITLE OF INVENTION: AQUEOUS LIQUID PREPARATION CONTAINING 2—AMINO—3—(4—BROMOBENZOYL)PHENYLACETIC ACID
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE
`
`PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATE DUE
`
`nonprovisional
`
`UNDISCOUNTED
`
`SOROUSH, LAYLA
`
`$960
`
`1627
`
`1. Change of correspondence address or indication of "Fee Address" (37
`CFR 1.363).
`
`3 Chan e of correspondence address (or Change of Correspondence
`Address orm PTO/SB/ 122) attached.
`
`3 "Fee Address" indication (or "Fee Address" Indication form
`PTO/SB/47; Rev 03—02 or more recent) attached. Use of a Customer
`Vumber is required.
`
`
`
`
`
`$0
`
`$0
`
`$960
`
`07/21/2014
`
`514—619000
`
`2. For printing on the patent front page, list
`(1) The names of up to 3 registered patent attorneys
`or agents OR, alternatively,
`(2) The name of a single firm (having as a member a
`registered attorney or agent) and the names of up to
`2 registered patent attorneys or agents. If no name is
`listed, no name will be printed.
`
`
`
`
`
`2
`
`3
`
`3. ASSIGNEE NAME AND RESIDENCE DATA TO BE PRINTED ON THE PATENT (print or type)
`If an assignee is identified below, the document has been filed for
`PLEASE NOTE: Unless an assignee is identified below, no assignee data will appear on the patent.
`recordation as set forth in 37 CFR 3.11. Completion of this form is NOT a substitute for filing an assignment.
`(A) NAME OF ASSIGNEE
`(B) RESIDENCE: (CITY and STATE OR COUNTRY)
`
`Please check the appropriate assignee category or categories (will not be printed on the patent) :
`
`'3 Individual
`
`'3 Corporation or other private group entity '3 Government
`
`4a. The following fee(s) are submitted:
`3 Issue Fee
`
`4b. Payment of Fee(s): (Please first reapply any previously paid issue fee shown above)
`3 A check is enclosed.
`
`
`
`3 Publication Fee (No small entity discount permitted)
`3 Advance Order — # of Copies
`
`5. Change in Entity Status (from status indicated above)
`3 Applicant certifying micro entity status. See 37 CFR 1.29
`
`3 Applicant asserting small entity status. See 37 CFR 1.27
`
`3 Applicant changing to regular undiscounted fee status.
`
`
`
`3 Payment by credit card. Form PTO—2038 is attached.
`3 The Director is hereby authorized to charge the required fee(s), any deficiency, or credits any
`overpayment, to Deposit Account Number
`(enclose an extra copy of this form).
`
`VOTE: Absent a valid certification of Micro Entity Status (see forms PTO/SB/ 15A and 15B), issue
`fee payment in the micro entity amount will not be accepted at the risk of application abandonment.
`VOTE: If the application was previously under micro entity status, checking this box will be taken
`to be a notification of loss of entitlement to micro entity status.
`VOTE: Checking this box will be taken to be a notification of loss of entitlement to small or micro
`entity status, as applicable.
`
`NOTE: This form must be signed in accordance with 37 CFR 1.31 and 1.33. See 37 CFR 1.4 for signature requirements and certifications.
`
`Authorized Signature
`
`Typed or printed name
`
`
`Date
`
`Registration No.
`
`Page 14 of 145
`
`Page 2 of 3
`
`PTOL—85 Part B (10—13) Approved for use through 10/31/2013.
`
`OMB 0651—0033
`
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`
`Page 14 of 145
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`APPLICATION NO.
`
`FILING DATE
`
`
`
`
`F {ST NAMED INVENTOR
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`PO. Box 1450
`Alexandria1 Virginia 22313-1450
`www.uspto.gov
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`14/165,976
`
`01/28/2014
`
`Shirou SAWA
`
`2014—0075
`
`4523
`
`513
`
`7590
`
`04/21/2014
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`511640013
`
`Washington, DC 20005-1503
`
`SOROUSH,LAYLA
`
`1627
`
`DATE MAILED: 04/21/2014
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment to date is 0 day(s). If the issue fee is paid on the date that is three months after the
`mailing date of this notice and the patent issues on the Tuesday before the date that is 28 weeks (six and a half
`months) after the mailing date of this notice, the Patent Term Adjustment will be 0 day(s).
`
`If a Continued Prosecution Application (CPA) was filed in the above—identified application, the filing date that
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information Retrieval
`(PAIR) WEB site (http://pair.uspto.gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the Office of
`Patent Legal Administration at (571)—272—7702. Questions relating to issue and publication fee payments should be
`directed to the Customer Service Center of the Office of Patent Publication at 1—(888)—786—0101 or (571)—272—4200.
`
`Page 15 of 145
`PTOL—85 (Rev. 02/11)
`
`Page 3 0f 3
`
`Page 15 of 145
`
`

`

`OMB Clearance and PRA Burden Statement for PTOL-85 Part B
`
`The Paperwork Reduction Act (PRA) of 1995 requires Federal agencies to obtain Office of Management and
`Budget approval before requesting most types of information from the public. When OMB approves an agency
`request to collect information from the public, OMB (i) provides a valid OMB Control Number and expiration
`date for the agency to display on the instrument that will be used to collect the information and (ii) requires the
`agency to inform the public about the OMB Control Number’s legal significance in accordance with 5 CFR
`1320.5(b).
`
`The information collected by PTOL-85 Part B is required by 37 CFR 1.311. The information is required to obtain
`or retain a benefit by the public which is to file (and by the USPTO to process) an application. Confidentiality is
`governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 12 minutes to complete,
`including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary
`depending upon the individual case. Any comments on the amount of time you require to complete this form
`and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, PO. Box 1450, Alexandria,